MET Copy Number Gain Associates with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR Mutant Lung Cancer

被引：1
|
作者：
Yano, Seiji [1 ]
Nanjo, Shigeki [1 ]
Arai, Sachiko [1 ]
Takeuchi, Shinji [1 ]
Yamada, Tadaaki [1 ]
Okada, Yasunori [2 ]
Hata, Akito [3 ]
Katakami, Nobuyuki [3 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan
[2] Juntendo Univ, Tokyo, Japan
[3] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
CNS Metastasis; osimertinib; MET copy number gain; EGFR-TKI resistance;
D O I：
10.1016/j.jtho.2016.11.269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA08.03
引用
收藏
页码：S272 / S273
页数：2
相关论文
共 50 条
  • [31] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Bean, James
    Brennan, Cameron
    Shih, Jin-Yuan
    Riely, Gregory
    Viale, Agnes
    Wang, Lu
    Chitale, Dhananjay
    Motoi, Noriko
    Szoke, Janos
    Broderick, Stephen
    Balak, Marissa
    Chang, Wen-Cheng
    Yu, Chong-Jen
    Gazdar, Adi
    Pass, Harvey
    Rusch, Valerie
    Gerald, William
    Huang, Shiu-Feng
    Yang, Pan-Chyr
    Miller, Vincent
    Ladany, Marc
    Yang, Chih-Hsin
    Pao, William
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) : 20932 - 20937
  • [32] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Bean, James
    Brennan, Cameron
    Shih, Jin-Yuan
    Riely, Gregory
    Viale, Agnes
    Wang, Lu
    Chitale, Dhananjay
    Motoi, Noriko
    Szoke, Janos
    Broderick, Stephen
    Balak, Marissa
    Chang, Wen-Cheng
    Yu, Chong-Jen
    Gazdar, Adi
    Pass, Harvey
    Rusch, Valerie
    Gerald, William
    Huang, Shiu-Feng
    Yang, Pan-Chyr
    Miller, Vincent
    Ladanyi, Marc
    Yang, Chih-Hsin
    Pao, William
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3333S - 3334S
  • [33] Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer
    Eser, Pinar O.
    Paranal, Raymond M.
    Poitras, Michael J.
    Xu, Man
    Wang, Stephen
    Ogino, Atsuko
    Choi, Jihyun
    Missios, Pavlos
    Haikala, Heidi M.
    Son, Jieun
    Lin, Mika
    Yanagita, Masahiko
    Gokhale, Prafulla C.
    Daley, George Q.
    Janne, Pasi A.
    CANCER RESEARCH, 2019, 79 (13)
  • [34] TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells
    Cui, Zhilei
    Liu, Zhen
    Zeng, Junxiang
    Zhang, Shulin
    Chen, Lei
    Zhang, Guorui
    Xu, Weiguo
    Song, Lin
    Guo, Xuejun
    LIFE SCIENCES, 2019, 224 : 23 - 32
  • [35] Gain of copy number and amplification of the RET gene in lung cancer
    Yang, Hai-Su
    Horten, Bruce
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 465 - 469
  • [36] Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer
    Ach, Tobias
    Zeitler, Katharina
    Schwarz-Furlan, Stephan
    Baader, Katharina
    Agaimy, Abbas
    Rohrmeier, Christian
    Zenk, Johannes
    Gosau, Martin
    Reichert, Torsten E.
    Brockhoff, Gero
    Ettl, Tobias
    VIRCHOWS ARCHIV, 2013, 462 (01) : 65 - 72
  • [37] Resistance mechanisms to dual EGFR and MET inhibition in patients with EGFR-mutant MET-amplified non-small cell lung cancer
    Wang, K.
    Du, R.
    Roy, S.
    Vokes, N.
    Elamin, Y. Y.
    Hume, C. Bueno
    Skoulidis, F.
    Gay, C.
    Blumenschein, G.
    Fossella, F.
    Tsao, A.
    Lee, J. J.
    Rinsurongkawong, W.
    Rinsurongkawong, V.
    Gibbons, D.
    Vaporciyan, A.
    Zhang, J.
    Heymach, J.
    Altan, M.
    Le, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1016 - S1016
  • [38] Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer
    Tobias Ach
    Katharina Zeitler
    Stephan Schwarz-Furlan
    Katharina Baader
    Abbas Agaimy
    Christian Rohrmeier
    Johannes Zenk
    Martin Gosau
    Torsten E. Reichert
    Gero Brockhoff
    Tobias Ettl
    Virchows Archiv, 2013, 462 : 65 - 72
  • [39] Mechanisms of Osimertinib Resistance in EGFR Mutant Lung Cancer
    Westover, D.
    Qiao, H.
    Ichihara, E.
    Meador, C. B.
    Lovly, C. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1546 - S1546
  • [40] Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
    Hironori Uruga
    Shuhei Moriguchi
    Yui Takahashi
    Kazumasa Ogawa
    Kyoko Murase
    Sayaka Mochizuki
    Shigeo Hanada
    Hisashi Takaya
    Atsushi Miyamoto
    Nasa Morokawa
    Kazuma Kishi
    BMC Cancer, 18
12345